Nutrition as Medicine: from research to implementation

  • Funded by Canadian Institutes of Health Research (CIHR)
  • Total publications:251 publications

Grant number: Unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    2020
  • Known Financial Commitments (USD)

    $112,498.5
  • Funder

    Canadian Institutes of Health Research (CIHR)
  • Principal Investigator

    N/A

  • Research Location

    Canada
  • Lead Research Institution

    CIUSSS du Centre-Sud-de-l'Île-de-Montréal
  • Research Priority Alignment

    N/A
  • Research Category

    Secondary impacts of disease, response & control measures

  • Research Subcategory

    Indirect health impacts

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Google translate: Malnutrition and weight loss are endemic in long-term care facilities (LTCFs). Yet their consequences are serious, including an increased risk of mortality and morbidity such as pressure sores and respiratory infections. This reality has been exacerbated during the pandemic. LTCF responders report that those with COVID-19 have seen their nutritional status deteriorate rapidly. At the same time, unaffected residents also exhibited significant and undesirable weight loss. Interventions to prevent weight loss should aim to increase energy and protein intake. The use of oral nutritional supplements is a popular way to achieve this goal. However, the actual consumption of these products is rather low. Since 2017, an intervention dubbed NAM for "Nutrition as Medication" has been developed and tested in LTCH by our team. This intervention suggests prescribing small doses of an oral nutritional supplement (30 or 60 ml) which are administered as a medicine. The effectiveness of NAM has been studied. Preliminary results show a high delivery rate (93-95%), a significant improvement in nutritional status and a decrease in pressure ulcers among residents. Following these results, a guide was written describing the NAM intervention, the principles that frame it, and the suggested strategy for successful implementation in an LTCF. The NAM intervention appears to be a promising practice that could limit or even prevent the deterioration of the nutritional status of residents, whether or not they have COVID-19. However, the studies were carried out before the onset of the pandemic and the implementation guide therefore does not take this context into account. Thus, with the aim of better equipping LTCFs during the new wave of COVID-19, our team proposes the dissemination and scaling up of the NAM intervention in LTCFs. Specifically, we propose to: 1) support the implementation of NAM within two Montreal ESLDs; 2) to evaluate the implementation of the NAM in terms of prescription and administration of the treatment; 3) identify facilitating and constraining factors for NAM implementation; 4) identify the effects of NAM as perceived by workers and relatives/residents; and 5) review NAM implementation hardware.]

Publicationslinked via Europe PMC

Last Updated:7 hours ago

View all publications at Europe PMC

Developing injury and illness epidemiology and surveillance in cycling (PhD Academy Award).

Effects of Hand-Rearing and Group Size on Chimpanzee (Pan troglodytes) Social Competence in Captivity.

Revisiting Spirituality in Physical Therapy Practice: Perceptions of US Practitioners.

Aflibercept for Wet Age-Related Macular Degeneration: A Prospective, Randomized Trial Comparing Treat-And-Extend and Fixed Bimonthly Dosing.

The Concentration and Duration of Lipopolysaccharide Stimulation Produce Different Cytokine Responses in an Ex Vivo Whole Blood Model in Horses.

History of Shrimp Farming and the Main Viral and Bacterial Diseases in Mexico.

Identification of Risk Factors in Patients with Recurrent Cystitis May Improve Individualized Management.

IS<i>Apl4</i>, a New IS<i>1595</i> Family Insertion Sequence Forming a Novel Pseudo-Compound Transposon That Confers Antimicrobial Multidrug Resistance in <i>Actinobacillus pleuropneumoniae</i>.

Living with Dysphagia and Dysarthria: A Qualitative Exploration of the Perspectives of People with Motor Neuron Disease and Their Caregivers.